Featuring exclusive insights, professional development opportunities, and industry-first resources, The DeepDive empowers healthcare marketers to excel in an increasingly competitive landscape.
NEW YORK, Aug. 21, 2024 /PRNewswire/ — DeepIntent, the health advertising platform, today launched The DeepDive, a must-have resource hub for healthcare marketers looking to stay ahead in a rapidly evolving industry. This platform provides exclusive, data-driven insights, continuing education opportunities, and interviews with top industry leaders to help marketers drive innovation and improve health outcomes.
The DeepDive offers a comprehensive suite of content, tools, and community-based resources tailored to the unique needs of healthcare marketers. Key offerings include:
Notable features of The DeepDive include the all-new podcast Deep: The Health Marketing Podcast and an industry-first digital health marketing certification program. Both are designed to provide ongoing professional development and ensure marketers remain competitive in a fast-paced industry.
“With rapidly changing privacy rules, new technologies, and growing pressure to do more with less, healthcare marketers face higher expectations than ever,” said Chris Paquette, Founder and CEO of DeepIntent. “A gap is emerging between marketers who rise to these challenges and those who fall behind. The DeepDive will be an invaluable resource, offering insights and education to elevate health advertising and keep marketers ahead of the curve.”
For more information about The DeepDive, visit www.deepintent.com/the-deep-dive.
About DeepIntent
DeepIntent is the health advertising platform marketers trust to drive effective campaigns. Purpose-built for healthcare and privacy-safe, the DeepIntent platform unites media, identity, and clinical data to produce industry-defining health intelligence. Consistently proven to deliver real-world results based on real-time optimization, the DeepIntent platform powers more than 600 pharmaceutical brands and all the leading healthcare agencies to innovate, differentiate, and reach their audiences across all channels and devices. For more information, visit DeepIntent.com or find us on LinkedIn.
Press Contacts
Stefanie DeSantis
stefanie.desantis@deepintent.com
Chris Shattuck
chris.shattuck@finnpartners.com
404-502-6755
FINN Partners on behalf of DeepIntent
SOURCE DeepIntent
Young Women Activists Launch "What Girls Want," Demand World Leaders Put Girls at the Center…
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may…
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the…
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment…
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC: SMFL) (“Smart for…
SAN FRANCISCO, Sept. 20, 2024 /PRNewswire/ -- The Global Ultrasound Institute (GUSI) is proud to…